Last reviewed · How we verify

NCT06094686

Epicardial Adipose Tissue Thickness and the Related Factors in Patients With Ankylosing Spondylitis

Completed Last updated 20 February 2024
What this trial tests

trial testing epicardial adipose tissue thickness in Ankylosing Spondylitis in 61 participants. Completed in 2 January 2016.

Timeline
1 August 2015
Primary endpoint
1 January 2016
2 January 2016

Quick facts

Lead sponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment61
Start date1 August 2015
Primary completion1 January 2016
Estimated completion2 January 2016
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Who can join

Adults 18 to 65, any sex, with Ankylosing Spondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to assess the EATT and the related factors in patients with AS and to compare the results with that of the healthy controls'

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ankylosing Spondylitis

Currently open trials in the same condition.

Other Istanbul Physical Medicine Rehabilitation Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06094686.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing